Severe asthma care trajectories: the French RAMSES cohort

Author:

Perotin Jeanne-Marie,Gauquelin Lisa,Just Nicolas,Devouassoux Gilles,Chenivesse Cécile,Bourdin ArnaudORCID,Garcia Gilles,Saint Raymond ChristelORCID,Boudjemaa Amel,Bonniaud Philippe,Chanez PascalORCID,Barnig CindyORCID,Beurnier AntoineORCID,Maurer Cyril,Freymond Nathalie,Didi Toufik,Tcherakian Colas,Russier Maud,Drucbert Mélanie,Guillo Sylvie,Estellat Candice,Taillé CamilleORCID

Abstract

BackgroundThe French RAMSES study is an observational prospective multicentre real-life cohort including severe asthmatic subjects. The objective of the study was to compare the characteristics of patients, in terms of phenotype and asthma care trajectories, between those managed by tertiary referral centres (TRCs) or secondary care centres (SCCs).MethodsPatients were prospectively recruited and enrolled for a 5-year follow-up. Patients’ characteristics were analysed at inclusion and compared between TRCs and SCCs.Results52 centres (24 TRCs and 28 SCCs) included 2046 patients: 1502 (73.4%) were included by a TRC and 544 (26.6%) by a SCC. Patients were mainly women (62%), 53±15 years old, 67% with Asthma Control Test <20; at inclusion, 14% received oral corticosteroids (OCS) and 66% biologics. Compared with the SCC group, the TRC group had more frequent comorbidities and lower blood eosinophil counts (262versus340 mm−3; p=0.0036). OCS and biologics use did not differ between groups, but patients in the TRC group benefited more frequently from an educational programme (26%versus18%; p=0.0008) and received more frequently two or more sequential lines of biologics (33%versus24%; p=0.0105). In-depth investigations were more frequently performed in the TRC group (allergy tests: 74%versus62%; p<0.0001; exhaled nitric oxide fraction: 56%versus21%; p<0.0001; induced sputum: 6%versus3%; p=0.0390).ConclusionsPhenotypes and care trajectories differed in the RAMSES cohort between SCCs and TRCs, probably related to different levels of asthma severity and differences in medical resources and practices among centres. This highlights the need for standardisation of severe asthma care.

Funder

Sanofi

AstraZeneca

GlaxoSmithKline

Société de Pneumologie de Langue Française

Boston Scientific Corporation

Novartis

Publisher

European Respiratory Society (ERS)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3